A case of severe ARIA with multiple infarctions and extensive microbleeds following lecanemab administration
2024

Severe ARIA after Lecanemab Treatment

Sample size: 1 publication Evidence: moderate

Author Information

Author(s): A. Yamazaki, T. Sekine, S. Takahashi, K. Sohara, M. Sakamaki, T. Nagao, K. Kimura, M. Mishina

Primary Institution: Nippon Medical School

Hypothesis

Can lecanemab treatment lead to severe amyloid-related imaging abnormalities (ARIA) with multiple infarctions and extensive microbleeds?

Conclusion

The case highlights the occurrence of severe ARIA with numerous microbleeds and cerebral microinfarctions following lecanemab treatment.

Supporting Evidence

  • The patient developed numerous microbleeds and cerebral microinfarctions after lecanemab treatment.
  • Previous studies reported limited microbleeds in severe ARIA cases, making this case unique.
  • Despite numerous microbleeds, there was no evidence of superficial siderosis.
  • The patient exhibited severe changes sufficient to cause a midline shift, necessitating intensive care.

Takeaway

One patient had serious side effects after taking a new Alzheimer's drug, showing many small brain bleeds and strokes.

Methodology

The patient was treated with lecanemab and monitored through MRI and cognitive assessments.

Limitations

The APOE genotype was not assessed due to lack of genetic testing coverage.

Participant Demographics

57-year-old married woman with 16 years of education.

Digital Object Identifier (DOI)

10.1111/psyg.13231

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication